Kyoko Fukuda

Title: Kyoko Fukuda: Innovator in T-Cell Receptor Research

Introduction

Kyoko Fukuda is a prominent inventor based in Kashiwa, Japan. She has made significant contributions to the field of immunology, particularly in the development of T-cell receptors that have potential applications in cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapeutic strategies.

Latest Patents

Kyoko Fukuda's latest patents include a T-cell receptor capable of binding to specific peptides associated with glypican-3 expression. The first patent describes a T-cell receptor that can bind to a peptide with the amino acid sequence shown in SEQ ID NO: 27 or a complex of the peptide and HLA-A24. The second patent focuses on a T-cell receptor that binds to a peptide with the amino acid sequence shown in SEQ ID NO: 28 or a complex of the peptide and HLA-A02. These T-cell receptors are particularly useful in treating or preventing cancers linked to glypican-3 expression. Additionally, she has developed a method for producing helper T cells from pluripotent stem cells, which is a significant advancement in cellular therapy.

Career Highlights

Kyoko Fukuda has worked at esteemed institutions such as Kyoto University and the National Cancer Center Japan. Her research has been instrumental in advancing our understanding of T-cell biology and its implications for cancer therapy.

Collaborations

She has collaborated with notable colleagues, including Shin Kaneko and Yasushi Uemura, to further her research initiatives and enhance the impact of her work in the scientific community.

Conclusion

Kyoko Fukuda's innovative research in T-cell receptors and cellular therapy highlights her as a key figure in the fight against cancer. Her contributions are expected to have a lasting impact on the field of immunology and cancer treatment.